Acurx pharmaceuticals to discuss fourth quarter and full year 2021 financial results and provide business update

Staten island, n.y., march 7, 2022 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will release its fourth quarter 2021 and fiscal year end 2021 financial results on thursday, march 17, 2022, at 8:30 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking